Diamond-Blackfan anemia
MONDO:0015253A congenital aregenerative and often macrocytic anemia with erythroblastopenia.
Also known as: Aase syndrome, Aase-Smith II syndrome, Blackfan-Diamond anaemia, Blackfan-Diamond anemia, DBA, Diamond Blackfan Anemia, Diamond-Blackfan anemia, chronic constitutional pure red cell anemia
26 clinical trials for this condition and its sub-types, 17 tagged with Diamond-Blackfan anemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Diamond-Blackfan anemia
-
Diamond-Blackfan anemia 1 1 trial
-
Diamond-Blackfan anemia 10 0 trials
-
Diamond-Blackfan anemia 11 0 trials
-
Diamond-Blackfan anemia 12 0 trials
-
Diamond-Blackfan anemia 13 0 trials
-
Diamond-Blackfan anemia 16 0 trials
-
Diamond-Blackfan anemia 17 0 trials
-
Diamond-Blackfan anemia 18 0 trials
-
Diamond-Blackfan anemia 19 0 trials
-
Diamond-Blackfan anemia 2 0 trials
-
Diamond-Blackfan anemia 20 0 trials
-
Diamond-Blackfan anemia 21 0 trials
-
Diamond-Blackfan anemia 22 0 trials
-
Diamond-Blackfan anemia 3 0 trials
-
Diamond-Blackfan anemia 4 0 trials
-
Diamond-Blackfan anemia 5 0 trials
-
Diamond-Blackfan anemia 6 0 trials
-
Diamond-Blackfan anemia 7 0 trials
-
Diamond-Blackfan anemia 8 0 trials
-
Diamond-Blackfan anemia 9 0 trials
-
Mismatched donor stem cell transplant could widen treatment access for sickle cell disease
Disease control Recruiting nowThis study tests a stem cell transplant using cells from mismatched unrelated or partially matched family donors for people with severe sickle cell disease and other transfusion-dependent anemias. The approach removes certain immune cells (T-cells) from the donated stem cells to …
Phase 1/2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Gene therapy could free kids from lifelong blood transfusions
Disease control Recruiting nowThis early-stage trial tests a one-time gene therapy called APR-2020 in 4 children with a severe form of Diamond-Blackfan anemia. The treatment uses the child's own blood stem cells, modified to correct the genetic defect, and given back as an infusion. The goal is to see if it i…
Phase 1 • Sponsor: Apriligen, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New stem cell transplant trial aims to treat sickle cell disease and other blood disorders
Disease control Recruiting nowThis phase 2 trial tests a stem cell transplant from a donor for people with high-risk sickle cell disease, thalassemia, and other red blood cell disorders. Participants receive drugs and low-dose radiation before the transplant to help the new cells take hold. The study will tra…
Phase 2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Milder chemo before stem cell transplant shows promise for rare blood disorders
Disease control Recruiting nowThis study tracks 50 children and adults with non-malignant disorders like immune deficiencies and anemias who receive a stem cell transplant after a reduced-intensity chemotherapy regimen. The goal is to see if this approach improves survival and reduces severe graft-versus-host…
Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Milder transplant method aims to help young patients with rare blood diseases
Disease control Recruiting nowThis study is testing a less intense chemotherapy and radiation regimen before a stem cell transplant for children and young adults up to age 55 with non-cancerous blood disorders like immune deficiencies, anemias, and metabolic diseases. The goal is to see if this gentler prepar…
Phase 2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Massive study aims to uncover cancer secrets in rare bone marrow diseases
Knowledge-focused Recruiting nowThis natural history study follows up to 4,000 people with inherited bone marrow failure syndromes (IBMFS) and their families to learn why they are prone to certain cancers. Researchers will track health over time, collect genetic samples, and look for clues that separate those w…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Hunt for hidden cancer genes: families needed to unlock hereditary secrets
Knowledge-focused Recruiting nowThis study aims to discover new genes that may cause certain cancers to run in families. Researchers will collect blood samples and health information from 1,500 people in families where multiple members have had cancer, especially childhood cancers. The goal is to build a regist…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Massive gene hunt aims to unlock secrets of blood disorders
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, and other samples along with health information from up to 1,716 people with non-cancerous blood diseases and their family members. Researchers will analyze the participants' genes to find new genetic causes of these conditions and understa…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
First step toward gene therapy for rare anemia: can stem cells be harvested?
Knowledge-focused Recruiting nowThis study checks if people with Diamond Blackfan Anemia (ages 3-30) can produce enough blood stem cells for future gene therapy. Participants receive two drugs to move stem cells from bone marrow into the blood, then researchers measure the cell count. No actual stem cell collec…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New registry aims to unlock secrets of rare anemia
Knowledge-focused Recruiting nowThis study is building a large database of people with Diamond Blackfan anemia, a rare inherited bone marrow condition that causes anemia. Researchers will collect medical information from up to 900 participants to better understand how the disease develops and progresses. The go…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC